228
Participants
Start Date
September 30, 2007
Primary Completion Date
August 31, 2010
Study Completion Date
August 31, 2010
Mircera
Starting dose of 120, 200 and 360 micrograms administered by subcutaneous injection once a month.
Darbepoetin alfa
As prescribed, subcutaneous injection once every week, once every 2 weeks or once every month as per local labeling specifications.
Budapest
Gosford
Lismore
Esztergom
Vác
Reservoir
Richmond
Kecskemét
Kalocsa
Baja
Hódmezővásárhely
Szigetvár
Roeselare
Aalst
Mineola
Ciudad Real
Berlin
Prague
Orchard Park
Prague
A Coruña
Genova
Demmin
La Spezia
S Fermo Della Battaglia
Nahariya
Lecco
Salem
Brescia
Lleida
Morgantown
Lodi
Pavia
Raleigh
Madrid
Málaga
Augusta
Lauderdale Lakes
Rennes
Mariánské Lázně
Bad Hersfeld
Chattanooga
Hadera
La Tronche
Saint-Priest-en-Jarez
Nantes
Ferrara
Dortmund
Kfar Saba
Orléans
Prato
Bonn
Bad König
Chieti
Strasbourg
Paris
Rehovot
München
Palermo
Jerusalem
Granada Hills
Coburg
Oregon City
Providence
Adelaide
Calgary
St. John's
Kingston
Mississauga
Toronto
Toronto
Montreal
Prague
Roma
Gdansk
Katowice
Lodz
Radom
Rzeszów
Sieradz
Szczecin
Warsaw
Barcelona
Barcelona
Barcelona
L'Hospitalet de Llobregat
Partida La Ceñuela. Torreviej
Belfast
Birmingham
Bradford
Exeter
Hoffmann-La Roche
INDUSTRY